欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > TyrosineKinase/Adaptors > RXDX-106 (CEP-40783)

浏览历史

S81334

RXDX-106 (CEP-40783)

源叶(MedMol) ≥98%
  • 英文名:
  • RXDX-106 (CEP-40783)
  • 别名:
  • CAS号:
  • 1437321-24-8
  • 分子式:
  • C31H26F2N4O6
  • 分子量:
  • 588.558
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S81334-1mg ≥98% ¥360.00元 10 - - - EA 加入购物车
源叶(MedMol) S81334-5mg ≥98% ¥1090.00元 10 - - - EA 加入购物车
源叶(MedMol) S81334-10mg ≥98% ¥1750.00元 8 - - - EA 加入购物车
源叶(MedMol) S81334-25mg ≥98% ¥3934.00元 3 - - - EA 加入购物车
源叶(MedMol) S81334-50mg ≥98% ¥7086.00元 1 - - - EA 加入购物车
源叶(MedMol) S81334-100mg ≥98% ¥12450.00元 1 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: CEP-40783 is a potent, selective and orally available inhibitor of AXL and c-Met with IC50 values of 7 nM and 12 nM, respectively.
  • 靶点: IC50: 7 nM (AXL) and 12 nM (c-Met);c-Met/HGFR; TAMReceptor
  • 体内研究:
    CEP-40783 shows dose- and time-dependent inhibition of AXL phosphorylation using NCI-H1299 NSCL xenografts with 80% target inhibition at 0.3 mg/kg 6 h post dose and complete target inhibition to >90% inhibition at 1 mg/kg between 6-24 h, while a 10 mg/kg po dose resulted in complete AXL inhibition up to 48 h post dosing. In 3/5 (60%) of the tumor models, CEP-40783 shows in vivo efficacy, including tumor regressions, significantly superior to that achieved with an optimal regimen of paclitaxel. In 4/4 (100%) of the erlotinib-insensitive tumor models, CEP-40783 demonstrates significant efficacy (66 to 118% TGI) compared to the control group at the 30 mg/kg dose. Additionally, CEP-40783 in combination with erlotinib demonstrate superior anti-tumor efficacy compared to CEP-40783 and erlotinib single agents in the one erlotinib-sensitive model evaluated. CEP-40783 as a single agent and in combination with erlotinib are well tolerated
  • 参考文献:
    1. Sheila M, et al. CEP-40783: A potent and selective AXL/c-Met inhibitor for use in breast, non-small cell lung (NSCLC), and pancreatic cancers. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therape 2. Jay F, et al. Antitumor activity of the dual AXL/c-Met inhibitor CEP-40783 in Champions primary TumorGraft models of human non-small cell lung cancer (NSCLC). [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets a
  • 溶解性: Soluble  in  DMSO
  • 保存条件: RT
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.699 ml 8.495 ml 16.991 ml
    5 mM 0.34 ml 1.699 ml 3.398 ml
    10 mM 0.17 ml 0.85 ml 1.699 ml
    50 mM 0.034 ml 0.17 ml 0.34 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。